EUVIMEDEUVIMED entdecken
Crossref

Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study

Hironobu Suto, Hiroyuki Matsukawa, Takuro Fuke, Mina Nagao, Yasuhisa Ando, Minoru Oshima, Hiroki Yamana, Hideki Kamada, Hideki Kobara, Hiroyuki Okuyama, Kensuke Kumamoto, Keiichi Okano

Pancreatology · 2024

DOI: 10.1016/j.pan.2024.02.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Hironobu Suto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan. Electronic address: suto.hironobu@kagawa-u.ac.jp. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: /Objective: Preoperative treatment of resectable pancreatic ductal adenocarcinoma (PDAC) is gaining popularity worldwide. However, the characteristics of tumors located in the pancreatic head (Ph), or those in the body or tail (Pbt), after surgery following neoadjuvant chemoradiotherapy (NACRT) remain unclear. This study aimed to evaluate and compare the clinicopathological features, perioperative outcomes, and prognosis of patients with resectable PDAC who underwent NACRT followed by curative pancreatic resection, focusing on distinguishing between Ph and Pbt PDACs. METHODS: We included 107 patients with resectable PDAC who underwent curative resection following NACRT between 2009 and 2023. Clinicopathological features, perioperative and prognostic outcomes, recurrence patterns, and prognoses were compared between Ph and Pbt PDAC groups. RESULTS: Tumors were found in the Ph and Pbt in 64 and 43 patients, respectively. Albumin levels and lymphocyte-to-monocyte ratios after NACRT were significantly lower in the Ph group than in the Pbt group. The Pbt group showed significantly higher rates of positive peritoneal lavage cytology and serosal, arterial, and portal vein invasion than the Ph group did. Overall and recurrence-free survival were similar between the two groups. The most common site of initial postoperative recurrence was the lung only in both groups; however, the rate of peritoneal dissemination only was significantly higher in the Pbt group than in the Ph group. CONCLUSIONS: The prognoses based on tumor locations in the Ph and Pbt after surgery following NACRT are similar. Following the resection of resectable Pbt PDAC, the possibility of peritoneal dissemination recurrence should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalAdenocarcinomaHumansPrognosisNeoadjuvant TherapyRetrospective StudiesChemoradiotherapyPancreatectomy

Stichwörter der Autor:innen

ChemoradiationPancreatectomyPancreatic ductal adenocarcinomaPreoperative treatmentTumor location

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan. Electronic address: suto.hironobu@kagawa-u.ac.jp.
  • Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan; Department of Molecular Oncologic Pathology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.

Zitieren

APA

Suto, H., Matsukawa, H., Fuke, T., Nagao, M., Ando, Y., Oshima, M., Yamana, H., Kamada, H., Kobara, H., Okuyama, H., Kumamoto, K., & Okano, K. (2024). Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study. Pancreatology. https://doi.org/10.1016/j.pan.2024.02.007

Vancouver

Suto H, Matsukawa H, Fuke T, Nagao M, Ando Y, Oshima M, et al. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study. Pancreatology. 2024. doi:10.1016/j.pan.2024.02.007

BibTeX
@article{Suto2024,
  author = {Suto, Hironobu and Matsukawa, Hiroyuki and Fuke, Takuro and Nagao, Mina and Ando, Yasuhisa and Oshima, Minoru and Yamana, Hiroki and Kamada, Hideki and Kobara, Hideki and Okuyama, Hiroyuki and Kumamoto, Kensuke and Okano, Keiichi},
  title = {Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study},
  journal = {Pancreatology},
  year = {2024},
  doi = {10.1016/j.pan.2024.02.007}
}
Kostenlos starten →